ng-nitroarginine methyl ester has been researched along with Cochlear Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloch, W; Hess, A; Michel, O; Watanabe, K | 1 |
Hoshino, T; Iwasaki, S; Mineta, H; Mizuta, K; Nagura, M; Umemura, K | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Cochlear Diseases
Article | Year |
---|---|
Inhibition of inducible nitric oxide synthase lowers the cochlear damage by lipopolysaccharide in guinea pigs.
Topics: Animals; Cochlea; Cochlear Diseases; Enzyme Inhibitors; Guinea Pigs; Immunohistochemistry; Lipopolysaccharides; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 2000 |
Role of nitric oxide in focal microcirculation disorder of guinea pig cochlea.
Topics: Animals; Cochlea; Cochlear Diseases; Enzyme Inhibitors; Guinea Pigs; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Photochemistry; Reactive Oxygen Species; Regional Blood Flow; Vascular Diseases | 2001 |